Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc. (GH), executed a sale of 49,716 shares on June 8, 2026. The transaction occurred at an average price of $125.57 per share, resulting in a total value of approximately $6.24 million.
This sale adds to recent insider activity from Mr. Eltoukhy, who sold a series of smaller blocks of shares totaling 16,641 shares for an aggregate of roughly $2.09 million on June 5, 2026.
Insider sales can be motivated by a variety of personal financial considerations, such as portfolio diversification, tax planning, or adherence to pre-established trading plans, and do not necessarily indicate a change in the insider's view of the company's prospects.